Table 3

Baseline characteristics of patients with or without cerebral oedema

VariablesNo cerebral oedema (n=46)Cerebral oedema (n=40)P value
Age, year62 (54–66)59 (55–68)0.914
male34 (73.9)31 (77.5)0.699
Current smoking24 (52.2)19 (47.5)0.665
Current alcohol consumption9 (19.6)13 (32.5)0.170
Hypertension34 (73.9)29 (72.5)0.883
Diabetes16 (34.8)13 (32.5)0.823
Dyslipidaemia12 (26.1)10 (25.0)0.908
Coronary heart disease8 (17.4)8 (20.0)0.757
Prior stroke9 (19.6)13 (32.5)0.170
SBP on admission, mm Hg144.5±20.9145.2±25.70.795
DBP on admission, mm Hg84.3±13.287.0±15.70.582
Preprocedural NIHSS3 (1–6)5 (2–9)0.027
Time from occlusion to ER, day19 (13–27)11 (3–28)0.053
ASITN/SIR Score2 (2–3)2 (2–3)0.006
Left arterial occlusion26 (56.5)16 (40.0)0.126
Intracranial arterial occlusion25 (54.3)24 (60.0)0.597
Contralateral arterial occlusion6 (13.0)3 (7.5)0.628
Severe stenosis of other arteries20 (43.5)11 (27.5)0.124
Multiple infarction sites4 (8.7)3 (7.5)1.000
ASPECTS8 (7–9)8 (6–9)0.385
 Lentiform nucleus28 (60.9)21 (52.5)0.434
 Caudate nucleus7 (15.2)9 (22.5)0.387
 Internal capsule17 (37.0)15 (37.5)0.959
 Insula23 (50.0)20 (50.0)1.000
 M13 (6.5)2 (5.0)1.000
 M22 (4.3)13 (32.5)0.001
 M35 (10.9)5 (12.5)1.000
 M43 (6.5)3 (7.5)1.000
 M53 (6.5)8 (20.0)0.062
 M67 (15.2)5 (12.5)0.717
Glycated haemoglobin A1c, %6.5±0.86.5±0.70.399
Triglyceride, mmol/L1.6±0.51.6±0.50.992
Low-density lipoprotein, mmol/L2.5±0.42.5±0.50.430
GFR, mL/min107.2±9.3104.7±12.10.640
  • ASITN/SIR, American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology; ASPECTS, Alberta Stroke Program Early CT Score; DBP, diastolic blood pressure; ER, endovascular recanalisation; GFR, glomerular filtration rate; NIHSS, National Institute of Health Stroke Scale; SBP, systolic blood pressure.